Literature DB >> 24968736

Relationship between autoantibodies combination, metabolic syndrome components and diabetic complications in autoimmune diabetes in adults.

Kristina Blaslov1, Tomislav Bulum, Jadranka Knežević-Ćuća, Lea Duvnjak.   

Abstract

The aim of our study was to establish the possible association between double or triple antibody positivity and latent autoimmune diabetes (LADA) phenotype in the context of metabolic syndrome (MS) prevalence and its individual components. This cross-sectional study population comprised 69 islet cell antibody-positive patients coming for their comprehensive annual review. They were divided into three groups according to antibody positivity. Twenty-five (36.2 %) were male, mean age of 51 years with disease duration of 8 years. Twenty-eight (40.58 %) were positive only for GAD Abs, 26 (37.68 %) were positive for ICA and GAD Abs and 15 (21.74 %) were positive for GAD, ICA, and IA2 Abs. The lowest value of waist circumference, MS, and artherial hypertension prevalence was found in the group positive for all three antibodies. In the multinomial multivariate logistic regression model, MS was negatively associated with triple Abs positivity compared to single Ab positivity and double Abs positivity. Our results highlight the importance of inverse association between simultaneous Abs positivity for ICA, GAD, and IA2 with the MS and its components present in LADA patients. This inverse relationship might implicate that LADA patients are phenotypically closer to T1DM. The contribution of IA2 Ab positivity merits is to be considered in the determination of LADA phenotypes, while its diagnostic value needs to be clarified in future follow-up studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24968736     DOI: 10.1007/s12020-014-0331-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  26 in total

1.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

2.  Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Authors:  David B Sacks; Mark Arnold; George L Bakris; David E Bruns; Andrea Rita Horvath; M Sue Kirkman; Ake Lernmark; Boyd E Metzger; David M Nathan
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

3.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

4.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

Review 5.  The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus.

Authors:  A W van Deutekom; R J Heine; S Simsek
Journal:  Diabet Med       Date:  2007-11-19       Impact factor: 4.359

6.  Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma.

Authors:  M S Lan; J Lu; Y Goto; A L Notkins
Journal:  DNA Cell Biol       Date:  1994-05       Impact factor: 3.311

7.  Lipoprotein abnormalities in insulin-dependent diabetes mellitus.

Authors:  P H Winocour; P N Durrington; M Ishola; D C Anderson
Journal:  Lancet       Date:  1986-05-24       Impact factor: 79.321

8.  Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.

Authors:  Mohammed I Hawa; Hubert Kolb; Nanette Schloot; Huriya Beyan; Stavroula A Paschou; Raffaella Buzzetti; Didac Mauricio; Alberto De Leiva; Knud Yderstraede; Henning Beck-Neilsen; Jaakko Tuomilehto; Cinzia Sarti; Charles Thivolet; David Hadden; Steven Hunter; Guntram Schernthaner; Werner A Scherbaum; Rhys Williams; Sinead Brophy; Paolo Pozzilli; Richard David Leslie
Journal:  Diabetes Care       Date:  2012-12-17       Impact factor: 19.112

9.  LADA: time for a new definition.

Authors:  Maria J Redondo
Journal:  Diabetes       Date:  2013-02       Impact factor: 9.461

10.  Metabolic syndrome and autoimmune diabetes: action LADA 3.

Authors:  Mohammed I Hawa; Charles Thivolet; Didac Mauricio; Irene Alemanno; Elisa Cipponeri; David Collier; Steven Hunter; Raffaella Buzzetti; Alberto de Leiva; Paolo Pozzilli; Richard David G Leslie
Journal:  Diabetes Care       Date:  2008-10-22       Impact factor: 19.112

View more
  3 in total

Review 1.  Latent Autoimmune Diabetes in Adults and Metabolic Syndrome-A Mini Review.

Authors:  Niansi Pan; Shimei Yang; Xiaohong Niu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

2.  Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement.

Authors:  Ernesto Maddaloni; Nader Lessan; Alia Al Tikriti; Raffaella Buzzetti; Paolo Pozzilli; Maha T Barakat
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

3.  Is diabetic retinopathy affected by diabetes type? A retrospective study using electronic medical record data from patients with latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes.

Authors:  Wanyue Li; Zifang Cheng; Yanan Song; Yifan Fang; Ming Yang; Maonian Zhang
Journal:  Acta Diabetol       Date:  2021-06-13       Impact factor: 4.280

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.